WHO Releases Reports On Pandemic Framework Review, Implications Of Nagoya For Public Health 23/11/2016 by Catherine Saez, Intellectual Property Watch 4 Comments Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)The World Health Organization has published two advanced documents to be presented at the organisation’s Executive Board meeting in January. One relates to the review of the WHO mechanism for pandemic influenza preparedness, and the other to the public health implications of the implementation of an international treaty on genetic resources. The report [pdf] of the 2016 Pandemic Influenza Preparedness Framework Review Group is expected to be presented at the WHO Executive Board meeting from 23 January to 1 February. The agenda of the Executive Board meeting, with detailed notes on each item, is available here [pdf]. In the preface of the document, Christine Kaseba-Sata (Chair), and Theresa Tam (acting Chair), said, “The PIP Framework offers helpful insights for the sharing of other pathogens that require a rapid response and the equitable sharing of benefits.” “However, it is the view of the PIP Framework Review Group that the PIP Framework will only remain relevant if viruses continue to be shared and the need for clarification around the sharing of genetic sequence data and benefits is rapidly addressed,” they said. They also underlined the importance of the strengthening of capacity building and the need to increase influenza vaccine production. Separately, a report [pdf] on how the implementation of the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity might affect the sharing of pathogens, and the potential public health implications was also issued as an advance document to be presented at the EB in January. The WHO analysis found that as a central conclusion that: “(1) the Nagoya Protocol has implications for the public health response to infectious diseases, including influenza; and (2) these implications include opportunities to advance both public health and principles of fair and equitable sharing of benefits.” Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Related Catherine Saez may be reached at csaez@ip-watch.ch."WHO Releases Reports On Pandemic Framework Review, Implications Of Nagoya For Public Health" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
[…] The Review Group detailed key issues needing to be addressed, in particular the handling of Genetic Sequence Data. The report also includes comments on Standard Material Transfer Agreements 2 (SMTA2) and partnership contributions (IPW, WHO, 23 November 2017). […] Reply
[…] The first review of the PIP Framework was carried out in 2016 by a Review Group, which provided a report in November 2016, with a number of recommendations (IPW, WHO, 23 November 2016). […] Reply
[…] The first review of the PIP Framework was carried out in 2016 by a Review Group, which provided a report in November 2016, with a number of recommendations (IPW, WHO, 23 November 2016). […] Reply